stable formulations of anti-tigit antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of using them

摘要

the present invention relates to stable formulations of antibodies against t cell immunoreceptor with ig and itim (tigit) domains, optionally also containing a human anti-programmed death receptor 1 (pd-1) antibody or antigen binding fragment thereof . methods of treating various cancers and chronic infections with the formulations of the invention are also provided.